课题基金 / 基金详情

Drug safety and effectiveness in inflammatory musculoskeletal disease

Drug safety and effectiveness in inflammatory musculoskeletal disease
炎症性肌肉骨骼疾病的药物安全性和有效性
批准号：
343705
负责人：
Bernatsky Sasha R
金额：
$0.73万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Miscellaneous Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-01-01 至 2017-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=343705&lang=en
关键词：
Drug Safety And Effectiveness Health Economics Personalized Medicine Pharmacoepidemiology Systemic Lupus Vasculitis

项目摘要

项目成果

Bernatsky Sasha R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This application will bring together researchers from Canada and the Netherlands, with a focus on systemic lupus (SLE ) and vasculitis, both chronic, potentially life-threatening disease that poses a huge burden to patients, health care systems, and socie
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Environmental factors and risk of autoimmune rheumatic disease incidence and serology
Air pollution and systemic autoimmune rheumatic diseases
Hydroxychloroquine in systemic lupus
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
海外基金